Rituparna Das

4.2k total citations · 3 hit papers
67 papers, 1.5k citations indexed

About

Rituparna Das is a scholar working on Infectious Diseases, Epidemiology and Animal Science and Zoology. According to data from OpenAlex, Rituparna Das has authored 67 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 19 papers in Epidemiology and 12 papers in Animal Science and Zoology. Recurrent topics in Rituparna Das's work include SARS-CoV-2 and COVID-19 Research (27 papers), Animal Virus Infections Studies (12 papers) and COVID-19 Clinical Research Studies (8 papers). Rituparna Das is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (27 papers), Animal Virus Infections Studies (12 papers) and COVID-19 Clinical Research Studies (8 papers). Rituparna Das collaborates with scholars based in United States, India and Canada. Rituparna Das's co-authors include Alfred J. Saah, Jacqueline M. Miller, Susanne K. Kjær, Bethany Girard, Darin K. Edwards, David C. Montefiori, Brandon Essink, Barbara J. Kuter, Ying Chang and Jing Feng and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Medicine.

In The Last Decade

Rituparna Das

58 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Bivalent Omicron-Containing Booster Vaccine against Covid-19

2022 346 citations Spyros Chalkias, Charles Harper et al. profile →
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

2016 341 citations Susanne K. Kjær, Barbara J. Kuter et al. Clinical Infectious Diseases profile →
A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults

2025 18 citations José F. Cardona, Rituparna Das et al. Vaccine profile →

Peers

Countries citing papers authored by Rituparna Das

Since Specialization

Citations

This map shows the geographic impact of Rituparna Das's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rituparna Das with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rituparna Das more than expected).

Fields of papers citing papers by Rituparna Das

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rituparna Das. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rituparna Das. The network helps show where Rituparna Das may publish in the future.

Co-authorship network of co-authors of Rituparna Das

This figure shows the co-authorship network connecting the top 25 collaborators of Rituparna Das. A scholar is included among the top collaborators of Rituparna Das based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rituparna Das. Rituparna Das is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines 2025 ·Cell Reports ·Sandhya Bangaru, Abigail M. Jackson, Jeffrey Copps, Monica L. Fernández‐Quintero, Jonathan L. Torres, Sara T. Richey, Bartek Nogal, Leigh M. Sewall, Alba Torrents de la Peña, (unknown), Mimi Guebre‐Xabier, Bethany Girard, Rituparna Das, Kizzmekia S. Corbett, Robert A. Seder, Barney S. Graham, Darin K. Edwards, Nita Patel, Gale Smith, Andrew B. Ward	0
2	Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345, an mRNA Vaccine Against RSV, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 Years 2025 ·Clinical Infectious Diseases ·Jaya Goswami, José F. Cardona, Jorge Caso, Denise C. Hsu, Alana K. Simorellis, Lauren Wilson, Rakesh Dhar, Xiaowei Wang, Archana Kapoor, Avi Collins, (unknown), Lan Lan, Jiejun Du, Haiyu Zhou, Sonia Stoszek, Christine A. Shaw, Caroline Reuter, Eleanor Wilson, Rituparna Das	1
3	Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trial 2025 ·The Lancet Infectious Diseases ·Spyros Chalkias, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rahnuma Wahid, Darin K. Edwards, Jing Feng, Weiping Deng, Haiyu Zhou, (unknown), Verónica Urdaneta, Yamuna Devi Paila, Bethany Girard, Saul N. Faust, Stephen R. Walsh, Catherine A. Cosgrove, Jacqueline M. Miller, Rituparna Das	6
4	mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients 2025 ·Frontiers in Immunology ·Bethany Girard, Amparo L. Figueroa, Stephen C. De Rosa, M. Juliana McElrath, Jamil Azzi, (unknown), Umaporn Siangphoe, (unknown), Jacqueline M. Miller, Rituparna Das, Frances Priddy	0
5	Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial 2025 ·Nature Communications ·(unknown), Jiejun Du, Lan Lan, Archana Kapoor, Gonzalo Pérez Marc, (unknown), C.J. Duncan, (unknown), (unknown), Frances Priddy, Sanjay Garg, Sonia Stoszek, Christine A. Shaw, Jaya Goswami, Eleanor Wilson, Rituparna Das, Honghong Zhou, Lingyi Zheng	2
6	Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines 2024 ·Vaccine ·Yaniv Lustig, Noam Barda, (unknown), Victoria Indenbaum, Ili Margalit, Keren Asraf, Ram Doolman, Spyros Chalkias, Rituparna Das, (unknown), (unknown), Yitshak Kreiss, Gili Regev‐Yochay	2
7	A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children 2024 ·Expert Review of Vaccines ·Frances Priddy, Spyros Chalkias, Brandon Essink, (unknown), Adam Brosz, Ivan T. Lee, Jing Feng, LaRee Tracy, Weiping Deng, (unknown), Haiyu Zhou, Avika Dixit, (unknown), Bethany Girard, (unknown), Anne Yeakey, Jacqueline M. Miller, Rituparna Das, Barbara J. Kuter	6
8	Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults 2024 ·The Journal of Infectious Diseases ·Christine A. Shaw, Brandon Essink, Charles Harper, (unknown), Archana Kapoor, Rakesh Dhar, Lauren Wilson, (unknown), Catherine A. Panozzo, Eleanor Wilson, Alana K. Simorellis, Caroline Reuter, Sonia Stoszek, Grace Chen, Rituparna Das, Jaya Goswami	36
9	Safety and Immunogenicity of the mRNA-1273 Coronavirus Disease 2019 Vaccine in Solid Organ Transplant Recipients 2024 ·The Journal of Infectious Diseases ·Amparo L. Figueroa, Jamil Azzi, Bijan Eghtesad, Frances Priddy, (unknown), Umaporn Siangphoe, (unknown), (unknown), Bethany Girard, Haiyu Zhou, Jacqueline M. Miller, Rituparna Das	3
10	Safety and immunogenicity of a single-dose omicron-containing COVID-19 vaccination in adolescents: an open-label, single-arm, phase 2/3 trial 2024 ·The Lancet Infectious Diseases ·Amparo L. Figueroa, (unknown), (unknown), (unknown), Anne Yeakey, Weiping Deng, W. Xu, (unknown), (unknown), (unknown), Bethany Girard, Jacqueline M. Miller, Rituparna Das, Frances Priddy	1
11	Development of a rapid and ultra-sensitive RNA:DNA hybrid immunocapture based biosensor for visual detection of SARS-CoV-2 RNA 2023 ·PNAS Nexus ·(unknown), Jyoti Prakash, Rituparna Das, Sandeep B. Shelar, Ajay Saini, Susan Cherian, (unknown), P. A. Hassan, (unknown), Kinshuk Dasgupta, Hari S. Misra, Sheetal Uppal	3
12	1939. Who to Boost When: An Analysis of Dosing Interval and Age on COVID-19 Outcomes in the COVE Trial During the Delta and Omicron Waves 2023 ·Open Forum Infectious Diseases ·Dean Follmann, Xiaowei Wang, Peter B. Gilbert, Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Mary Marovich, Holly Janes, Weiping Deng, Frances Priddy, Avika Dixit, Joanne E. Tomassini, Rituparna Das, Jacqueline M. Miller, Haiyu Zhou	0
13	Analysis of Different Routes of Hysterectomy Based on a Prospective Algorithm and Their Complications in a Tertiary Care Institute 2022 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Rituparna Das, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	4
14	Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial 2022 ·Nature Medicine ·Laurence Chu, Keith Vrbicky, David C. Montefiori, Wenmei Huang, Biliana Nestorova, Ying Chang, Andrea Carfı́, Darin K. Edwards, Judy Oestreicher, Holly Legault, (unknown), Bethany Girard, Rolando Pajón, Jacqueline M. Miller, Rituparna Das, Brett Leav, Roderick McPhee	56
15	The pace of secular changes of body measurements of children and adolescents from Kolkata (India) in the context of socioeconomic inequalities between the sexes 2021 ·American Journal of Human Biology ·Łukasz Kryst, Magdalena Żegleń, Parasmani Dasgupta, (unknown), Rituparna Das, (unknown)	3
16	A study to assess the knowledge and awareness among young doctors about emergency contraception 2021 ·SHILAP Revista de lepidopterología ·(unknown), Rituparna Das, (unknown), Nalini Sharma, (unknown)	3
17	Coronavirus disease 2019: scientific overview of the global pandemic 2020 ·New Microbes and New Infections ·(unknown), Rituparna Das, Hari S. Misra, Sheetal Uppal	2
18	The relationship among the age at menarche, anthropometric characteristics, and socio‐economic factors in Bengali girls from Kolkata, India 2019 ·American Journal of Human Biology ·Magdalena Żegleń, Elisabetta Marini, Stefano Cabras, Łukasz Kryst, Rituparna Das, Anindita Chakraborty, Parasmani Dasgupta	12
19	Secular changes in limb lengths and proportions from 1952 to 2011 in children, adolescents, and young adults from Kolkata (India) 2019 ·American Journal of Human Biology ·Łukasz Kryst, Magdalena Żegleń, Parasmani Dasgupta, (unknown), Rituparna Das, (unknown)	5
20	A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries 2017 ·Clinical Infectious Diseases ·Susanne K. Kjær, Mari Nygård, Joakim Dillner, J. Brooke Marshall, David Radley, Meng Li, Christian Munk, Bo T. Hansen, Lára G. Sigurðardóttir, Maria Hortlund, Laufey Tryggvadóttír, Amita Joshi, Rituparna Das, Alfred J. Saah	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact